← back to search

Rima Al‐awar

Ontario Institute for Cancer Research ·
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, Acute Myeloid Leukemia Research, Protein Degradation and Inhibitors, and Lung Cancer Treatments and Mutations.
h-index
42
citations
5,941
works
251
NIH funding
primary concept
email

Recent publications

CACHE (Critical Assessment of Computational Hit-finding Experiments): A public–private partnership benchmarking initiative to enable the development of computational methods for hit-finding
Nature Reviews Chemistry 2022cited by 99position: middledoi
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival
Nature Communications 2021cited by 62position: middledoi
The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia
OncoImmunology 2021cited by 10position: middledoi
The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia
medRxiv 2021cited by 0position: middledoi
Functional characterization of a PROTAC directed against BRAF mutant V600E
Nature Chemical Biology 2020cited by 130position: middledoi
A drug discovery platform to identify compounds that inhibit EGFR triple mutants
Nature Chemical Biology 2020cited by 38position: middledoi
Discovery of an MLLT1/3 YEATS Domain Chemical Probe
Angewandte Chemie International Edition 2018cited by 94position: middledoi
Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer
Cell Reports 2017cited by 56position: middledoi
WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma
Cancer Research 2015cited by 123position: middledoi
BRAIN TUMOUR INITIATING CELLS AND TARGETING STAT3 ONCOGENIC SIGNALLING IN GBM
Neuro-Oncology 2014cited by 1position: middledoi
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
Nature Communications 2012cited by 286position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David Uehling · Hospital for Sick Children2 papers (2021–2021) · 2 papers (2021–2021) · 2 papers (2021–2021) · 2 papers (2021–2021) · 2 papers (2021–2021) · 2 papers (2021–2021)Andrea Arruda · Research Canada2 papers (2021–2021)Safoura Zangiabadi · York University2 papers (2021–2021) · 2 papers (2021–2021)Achire N. Mbanwi · Queen's University2 papers (2021–2021)Mark D. Minden · Toronto Public Health2 papers (2021–2021)Ali A. Abdul‐Sater · Columbia University2 papers (2021–2021) · 1 papers (2018–2018) · 1 papers (2017–2017) · 1 papers (2017–2017)Anne‐Marie Mes‐Masson · University of Ottawa1 papers (2017–2017) · 1 papers (2018–2018)O. Stechishin · Allen Institute for Brain Science1 papers (2014–2014) · 1 papers (2017–2017)Charline Giroud · Children's Healthcare of Atlanta1 papers (2018–2018)